Your payment is in progress...
  +1 (704) 266-3234

Global And Japan Congestive Heart Failure (CHF) Treatment Devices Market Insights, Forecast To 2026

Published on: Sep 2020 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 130

Congestive Heart Failure (CHF) Treatment Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Congestive Heart Failure (CHF) Treatment Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Congestive Heart Failure (CHF) Treatment Devices market is segmented into
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)

Segment by Application, the Congestive Heart Failure (CHF) Treatment Devices market is segmented into
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)

Regional and Country-level Analysis
The Congestive Heart Failure (CHF) Treatment Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Congestive Heart Failure (CHF) Treatment Devices market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Congestive Heart Failure (CHF) Treatment Devices Market Share Analysis
Congestive Heart Failure (CHF) Treatment Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Congestive Heart Failure (CHF) Treatment Devices business, the date to enter into the Congestive Heart Failure (CHF) Treatment Devices market, Congestive Heart Failure (CHF) Treatment Devices product introduction, recent developments, etc.
The major vendors covered:
Abiomed
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International
Jarvik Heart
LivaNova PLC
Medtronic
ReliantHeart
Abbott

1 Study Coverage
1.1 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
1.2 Market Segments
1.3 Key Congestive Heart Failure (CHF) Treatment Devices Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Type
1.4.2 Cardiac Resynchronization Therapy (CRT)
1.4.3 Implantable Cardioverter Defibrillators (ICDs)
1.5 Market by Application
1.5.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Application
1.5.2 Left Ventricular Assist Device (LVAD)
1.5.3 Right Ventricular Assist Device (RVAD)
1.5.4 Biventricular Assist Device (BIVAD)
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size, Estimates and Forecasts
2.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue 2015-2026
2.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales 2015-2026
2.2 Global Congestive Heart Failure (CHF) Treatment Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Congestive Heart Failure (CHF) Treatment Devices Historical Market Size by Region (2015-2020)
2.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Region (2021-2026)
2.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Region (2021-2026)

3 Global Congestive Heart Failure (CHF) Treatment Devices Competitor Landscape by Players
3.1 Global Top Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers
3.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers (2015-2020)
3.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Manufacturers (2015-2020)
3.2 Global Congestive Heart Failure (CHF) Treatment Devices Manufacturers by Revenue
3.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturers (2015-2020)
3.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2019
3.2.5 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Manufacturers
3.4 Global Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base Distribution, Product Types
3.4.1 Congestive Heart Failure (CHF) Treatment Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Type
3.4.3 Date of International Manufacturers Enter into Congestive Heart Failure (CHF) Treatment Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Type (2015-2020)
4.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2015-2020)
4.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2015-2020)
4.1.3 Congestive Heart Failure (CHF) Treatment Devices Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Type (2021-2026)
4.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2021-2026)
4.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Type (2021-2026)
4.2.3 Congestive Heart Failure (CHF) Treatment Devices Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Application (2015-2020)
5.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2015-2020)
5.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2015-2020)
5.1.3 Congestive Heart Failure (CHF) Treatment Devices Price by Application (2015-2020)
5.2 Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Application (2021-2026)
5.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2021-2026)
5.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Application (2021-2026)
5.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application
6.1 Japan Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
6.1.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales YoY Growth 2015-2026
6.1.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue YoY Growth 2015-2026
6.1.3 Japan Congestive Heart Failure (CHF) Treatment Devices Market Share in Global Market 2015-2026
6.2 Japan Congestive Heart Failure (CHF) Treatment Devices Market Size by Players (International and Local Players)
6.2.1 Japan Top Congestive Heart Failure (CHF) Treatment Devices Players by Sales (2015-2020)
6.2.2 Japan Top Congestive Heart Failure (CHF) Treatment Devices Players by Revenue (2015-2020)
6.3 Japan Congestive Heart Failure (CHF) Treatment Devices Historic Market Review by Type (2015-2020)
6.3.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2015-2020)
6.3.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2015-2020)
6.3.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price by Type (2015-2020)
6.4 Japan Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2021-2026)
6.4.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Type (2021-2026)
6.4.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Type (2021-2026)
6.5 Japan Congestive Heart Failure (CHF) Treatment Devices Historic Market Review by Application (2015-2020)
6.5.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2015-2020)
6.5.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2015-2020)
6.5.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price by Application (2015-2020)
6.6 Japan Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2021-2026)
6.6.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Application (2021-2026)
6.6.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Application (2021-2026)

7 North America
7.1 North America Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
7.2 North America Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
7.2.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2015-2020)
7.2.2 North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
8.2 Europe Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
8.2.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country
8.2.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
9.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
9.2.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2015-2020)
9.2.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
10.2 Latin America Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
10.2.1 Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country
10.2.2 Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
11.2.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country
11.2.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Abiomed
12.1.1 Abiomed Corporation Information
12.1.2 Abiomed Description and Business Overview
12.1.3 Abiomed Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.1.5 Abiomed Recent Development
12.2 Berlin Heart GmbH
12.2.1 Berlin Heart GmbH Corporation Information
12.2.2 Berlin Heart GmbH Description and Business Overview
12.2.3 Berlin Heart GmbH Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.2.5 Berlin Heart GmbH Recent Development
12.3 Biotronik SE & Co. KG
12.3.1 Biotronik SE & Co. KG Corporation Information
12.3.2 Biotronik SE & Co. KG Description and Business Overview
12.3.3 Biotronik SE & Co. KG Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.3.5 Biotronik SE & Co. KG Recent Development
12.4 Boston Scientific Corporation
12.4.1 Boston Scientific Corporation Corporation Information
12.4.2 Boston Scientific Corporation Description and Business Overview
12.4.3 Boston Scientific Corporation Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.4.5 Boston Scientific Corporation Recent Development
12.5 HeartWare International
12.5.1 HeartWare International Corporation Information
12.5.2 HeartWare International Description and Business Overview
12.5.3 HeartWare International Sales, Revenue and Gross Margin (2015-2020)
12.5.4 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.5.5 HeartWare International Recent Development
12.6 Jarvik Heart
12.6.1 Jarvik Heart Corporation Information
12.6.2 Jarvik Heart Description and Business Overview
12.6.3 Jarvik Heart Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.6.5 Jarvik Heart Recent Development
12.7 LivaNova PLC
12.7.1 LivaNova PLC Corporation Information
12.7.2 LivaNova PLC Description and Business Overview
12.7.3 LivaNova PLC Sales, Revenue and Gross Margin (2015-2020)
12.7.4 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.7.5 LivaNova PLC Recent Development
12.8 Medtronic
12.8.1 Medtronic Corporation Information
12.8.2 Medtronic Description and Business Overview
12.8.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Medtronic Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.8.5 Medtronic Recent Development
12.9 ReliantHeart
12.9.1 ReliantHeart Corporation Information
12.9.2 ReliantHeart Description and Business Overview
12.9.3 ReliantHeart Sales, Revenue and Gross Margin (2015-2020)
12.9.4 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.9.5 ReliantHeart Recent Development
12.10 Abbott
12.10.1 Abbott Corporation Information
12.10.2 Abbott Description and Business Overview
12.10.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Abbott Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.10.5 Abbott Recent Development
12.11 Abiomed
12.11.1 Abiomed Corporation Information
12.11.2 Abiomed Description and Business Overview
12.11.3 Abiomed Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Products Offered
12.11.5 Abiomed Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 PorterÕs Five Forces Analysis
13.5 Primary Interviews with Key Congestive Heart Failure (CHF) Treatment Devices Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Congestive Heart Failure (CHF) Treatment Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Congestive Heart Failure (CHF) Treatment Devices Market Segments
Table 2. Ranking of Global Top Congestive Heart Failure (CHF) Treatment Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Cardiac Resynchronization Therapy (CRT)
Table 5. Major Manufacturers of Implantable Cardioverter Defibrillators (ICDs)
Table 6. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Regions 2015-2020 (K Units)
Table 9. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Regions (2015-2020)
Table 10. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Manufacturers (2015-2020)
Table 14. Global Congestive Heart Failure (CHF) Treatment Devices Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Congestive Heart Failure (CHF) Treatment Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congestive Heart Failure (CHF) Treatment Devices as of 2019)
Table 16. Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Price (2015-2020) (USD/Unit)
Table 19. Congestive Heart Failure (CHF) Treatment Devices Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Type
Table 21. Date of International Manufacturers Enter into Congestive Heart Failure (CHF) Treatment Devices Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2015-2020) (K Units)
Table 24. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2015-2020)
Table 25. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2015-2020)
Table 27. Congestive Heart Failure (CHF) Treatment Devices Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2021-2026)
Table 29. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2015-2020) (K Units)
Table 30. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2015-2020)
Table 31. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2021-2026)
Table 32. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share Forecast by Application (2021-2026)
Table 35. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) of Key Companies (2015-2020)
Table 36. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Company (2015-2020)
Table 37. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) by Company (2015-2020)
Table 38. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Type (2015-2020)
Table 39. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2015-2020)
Table 40. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. Japan Congestive Heart Failure (CHF) Treatment Devices Price (K Units) by Type (2015-2020)
Table 42. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Type (2021-2026)
Table 43. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2021-2026)
Table 44. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2021-2026)
Table 46. Japan Congestive Heart Failure (CHF) Treatment Devices Price (K Units) by Type (2021-2026)
Table 47. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Application (2015-2020)
Table 48. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2015-2020)
Table 49. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Application (2021-2026)
Table 51. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2021-2026)
Table 52. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2021-2026)
Table 54. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2015-2020) (K Units)
Table 55. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2015-2020)
Table 56. North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2015-2020)
Table 58. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2015-2020) (K Units)
Table 59. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2015-2020)
Table 60. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2015-2020)
Table 66. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2015-2020) (K Units)
Table 67. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2015-2020)
Table 74. Abiomed Corporation Information
Table 75. Abiomed Description and Business Overview
Table 76. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product
Table 78. Abiomed Recent Development
Table 79. Berlin Heart GmbH Corporation Information
Table 80. Berlin Heart GmbH Description and Business Overview
Table 81. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Berlin Heart GmbH Product
Table 83. Berlin Heart GmbH Recent Development
Table 84. Biotronik SE & Co. KG Corporation Information
Table 85. Biotronik SE & Co. KG Description and Business Overview
Table 86. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Biotronik SE & Co. KG Product
Table 88. Biotronik SE & Co. KG Recent Development
Table 89. Boston Scientific Corporation Corporation Information
Table 90. Boston Scientific Corporation Description and Business Overview
Table 91. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Boston Scientific Corporation Product
Table 93. Boston Scientific Corporation Recent Development
Table 94. HeartWare International Corporation Information
Table 95. HeartWare International Description and Business Overview
Table 96. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. HeartWare International Product
Table 98. HeartWare International Recent Development
Table 99. Jarvik Heart Corporation Information
Table 100. Jarvik Heart Description and Business Overview
Table 101. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Jarvik Heart Product
Table 103. Jarvik Heart Recent Development
Table 104. LivaNova PLC Corporation Information
Table 105. LivaNova PLC Description and Business Overview
Table 106. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. LivaNova PLC Product
Table 108. LivaNova PLC Recent Development
Table 109. Medtronic Corporation Information
Table 110. Medtronic Description and Business Overview
Table 111. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Medtronic Product
Table 113. Medtronic Recent Development
Table 114. ReliantHeart Corporation Information
Table 115. ReliantHeart Description and Business Overview
Table 116. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. ReliantHeart Product
Table 118. ReliantHeart Recent Development
Table 119. Abbott Corporation Information
Table 120. Abbott Description and Business Overview
Table 121. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Abbott Product
Table 123. Abbott Recent Development
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Congestive Heart Failure (CHF) Treatment Devices Players
Table 128. Congestive Heart Failure (CHF) Treatment Devices Customers List
Table 129. Congestive Heart Failure (CHF) Treatment Devices Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Congestive Heart Failure (CHF) Treatment Devices Product Picture
Figure 2. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type in 2020 & 2026
Figure 3. Cardiac Resynchronization Therapy (CRT) Product Picture
Figure 4. Implantable Cardioverter Defibrillators (ICDs) Product Picture
Figure 5. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application in 2020 & 2026
Figure 6. Left Ventricular Assist Device (LVAD)
Figure 7. Right Ventricular Assist Device (RVAD)
Figure 8. Biventricular Assist Device (BIVAD)
Figure 9. Congestive Heart Failure (CHF) Treatment Devices Report Years Considered
Figure 10. Global Congestive Heart Failure (CHF) Treatment Devices Market Size 2015-2026 (US$ Million)
Figure 11. Global Congestive Heart Failure (CHF) Treatment Devices Sales 2015-2026 (K Units)
Figure 12. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2015-2020)
Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region in 2019
Figure 15. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2015-2020)
Figure 16. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region in 2019
Figure 17. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2019
Figure 19. Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2015-2020)
Figure 21. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type in 2019
Figure 22. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2015-2020)
Figure 23. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type in 2019
Figure 24. Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Price Range (2015-2020)
Figure 25. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2015-2020)
Figure 26. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application in 2019
Figure 27. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2015-2020)
Figure 28. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application in 2019
Figure 29. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2015-2026 (K Units)
Figure 30. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. Japan Congestive Heart Failure (CHF) Treatment Devices Market Share in Global Market 2015-2026
Figure 32. Japan 5 and 10 Largest Congestive Heart Failure (CHF) Treatment Devices Players Market Share by Revenue in Congestive Heart Failure (CHF) Treatment Devices in 2019
Figure 33. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2015-2020)
Figure 34. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate by Type in 2015 & 2019
Figure 35. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2015-2020)
Figure 36. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2015-2020 (K Units)
Figure 38. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country in 2019
Figure 40. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country in 2019
Figure 41. U.S. Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 42. U.S. Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 44. Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country in 2019
Figure 48. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country in 2019
Figure 49. Germany Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 52. France Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region in 2019
Figure 62. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region in 2019
Figure 63. China Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country in 2019
Figure 88. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country in 2019
Figure 89. Mexico Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country in 2019
Figure 99. Turkey Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Porter's Five Forces Analysis
Figure 106. Congestive Heart Failure (CHF) Treatment Devices Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $5850
USD $7800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.